CROI 2016 Program at a Glance

Program and Agenda

Session P-G4 Poster Abstracts

Hall A/B

413 Role of HCV Coinfection on CSF Biomarkers in HIV Patients Andrea Antinori 1 ;Valentina Fedele 1 ; Carmela Pinnetti 1 ; Patrizia Lorenzini 1 ; Stefania Carta 1 ;Veronica Bordoni 1 ; Federico Martini 1 ; Francesca Ceccherini-Silberstein 2 ; Adriana Ammassari 1 ; Carlo Federico Perno 2 1 InstNazionaleMalattie Infettive“L.Spallanzani”,Rome, Italy; 2 Univof RomeTorVergata,Rome, Italy 414 Psychiatric Symptoms Are Common in Acute HIV and CorrelateWith Disease Biomarkers Joanna M. Hellmuth 1 ; Chun-Zi Peng 2 ;VictorValcour 1 ; Donn Colby 3 ; PonpenTantivayakul 3 ; Shelly Krebs 4 ; Praphan Phanuphak 5 ; Serena S. Spudich 6 ; Robert Paul 2 ; for the RV254/SEARCH 010 Study Group 1 UnivofCaliforniaSanFrancisco,SanFrancisco,CA,USA; 2 Missouri Instof MentalHlth,St.Louis,MO,USA; 3 SEARCH,Bangkok,Thailand; 4 Military HIVRsrProg,Bethesda,MD,USA; 5 ThaiRedCrossAIDSRsrCntr,Bangkok, Thailand; 6 YaleUnivSchofMed,NewHaven,CT,USA 2:45 PM-4:00 PM Clinical Distinctions and Therapeutic Response 415 Neurologic Signs and Symptoms Frequently Manifest in Acute HIV Infection Joanna M. Hellmuth 1 ; James L. Fletcher 2 ;VictorValcour 1 ; Eugène Kroon 2 ; Jintanat Ananworanich 3 ; Linda Jagodzinski 3 ; Duanghathai Suttichom 2 ; Nittaya Phanuphak 2 ; Serena S. Spudich 4 ; for the SEARCH 010/RV254 Study Group 1 UnivofCaliforniaSanFrancisco,SanFrancisco,CA,USA; 2 SEARCH, Bangkok,Thailand; 3 MilitaryHIVRsrProg,Bethesda,MD,USA; 4 YaleUniv SchofMed,NewHaven,CT,USA 416 Male/Female Differences in Cognitive Function in HIV+ Individuals Pauline Maki 1 ; Leah Rubin 1 ; Gayle Springer 2 ; Ned Sacktor 3 ; Eric N. Miller 4 ;VictorValcour 5 ; MaryYoung 6 ; JamesT. Becker 7 ; Eric C. Seaberg 2 ; Eileen Martin 8 ; for the NeurocognitiveWorking Groups of theWomen’s Interagency HIV Study and the Multicenter AIDS Cohort Study 1 Univof IllinoisatChicago,Chicago, IL,USA; 2 JohnsHopkinsBloomberg SchofPH,Baltimore,MD,USA; 3 JohnsHopkinsUnivSchofMed, Baltimore,MD,USA; 4 UnivofCaliforniaLosAngeles,LosAngeles, CA,USA; 5 UnivofCaliforniaSanFrancisco,SanFrancisco,CA,USA; 6 GeorgetownUnivMedCntr,Washington,DC,USA; 7 UnivofPittsburgh, Pittsburgh,PA,USA; 8 RushUnivMedCntr,Chicago, IL,USA 417 CNS Safety of Simplification to ATV/r+3TC in Virologically Suppressed HIV+ Patients Nicoletta Ciccarelli 1 ; Massimiliano Fabbiani 2 ; Eugenia Quiros Roldan 3 ; Manuela Colafigli 4 ; Antonella Castagna 5 ; Roberta Gagliardini 2 ; Andrea De Luca 6 ; Simona Di Giambenedetto 2 ; Roberto Cauda 2 ; for the ATLAS-M Study Group 1 CatholicUniv,Rome, Italy; 2 InstofClinical InfectiousDiseases,Catholic UnivofSacredHeart,Rome, Italy; 3 UnivofBrescia,Brescia, Italy; 4 San GallicanoDermatological Inst, IRCCS,Rome, Italy; 5 SanRaffaeleScientific Inst,Milan, Italy; 6 UnivofSiena,Siena, Italy Session P-G5 Poster Abstracts Hall A/B

2:45 PM-4:00 PM Host and Virus Biomarkers and Immune Response 407 Dual Role of Activated and HIV-Specific CD8 T Cells in CSF During Acute HIV Infection LydieTrautmann 1 ; Cari Kessing 2 ; Eugène Kroon 3 ; Donn Colby 3 ; Shelly Krebs 4 ; Napapon Sailasuta 5 ; Jintana Intana 3 ;VictorValcour 6 ; Jintanat Ananworanich 4 ; Serena S. Spudich 7 ; for the SEARCH 010/011/013 Study Groups 1 MilitaryHIVRsrProg,SilverSpring,MD,USA; 2 TheScrippsRsr Inst, Jupiter,FL,USA; 3 SEARCH,Bangkok,Thailand; 4 MilitaryHIVRsrProg, Bethesda,MD,USA; 5 UnivofHawaii,Honolulu,HI,USA; 6 Univof CaliforniaSanFrancisco,SanFrancisco,CA,USA; 7 YaleUnivSchofMed, NewHaven,CT,USA 408 CD4/CD8 Ratio Decline and Risk of Neurocognitive Deterioration MatteoVassallo 1 ; Roxane Fabre 2 ; Jacques Durant 3 ; Christine Lebrun-Frenay 2 ; Brigitte Dunais 2 ; Muriel Laffon 2 ; Francine DeSalvador 2 ; Jacqueline Cottalorda 3 ; MichelTicchioni 2 ; Pierre Dellamonica 3 ; Christian Pradier 2 1 CntrHospierdeCannes,Cannes,France; 2 NiceUnivHosp,Nice,France; 3 CHUdeNice,Nice,France 409 Novel CSF Biomarker Associations With HIV-Associated Neurocognitive Disorder (HAND) Asha R. Kallianpur 1 ; Haley Gittleman 2 ; Scott R. Letendre 3 ; Ron Ellis 3 ; Jill Barnholtz-Sloan 4 ;William Bush 4 ; Robert Heaton 5 ; David Samuels 6 ; Todd Hulgan 7 ; for the CNS HIV AntiretroviralTherapy Effects Research (CHARTER) Study Group 1 ClevelandClinic/LernerRsr Inst,Cleveland,OH,USA; 2 CaseWestern ReserveUniv,Cleveland,OH,USA; 3 UnivofCaliforniaSanDiego,San Diego,CA,USA; 4 CaseWesternReserveUnivSchofMed,Cleveland,OH, USA; 5 UnivofCaliforniaSanDiego,La Jolla,CA,USA; 6 VanderbiltUnivSch ofMed,Nashville,TN,USA; 7 VanderbiltUniv,Nashville,TN,USA Martin Hoenigl 1 ; Michelli Faria de Oliveira 1 ; Josué Pérez-Santiago 1 ; Malcolm Finkelman 2 ;Yonglong Zhang 2 ; Sheldon R. Morris 1 ; Ron Ellis 1 ; Sara Gianella 1 1 UnivofCaliforniaSanDiego,SanDiego,CA,USA; 2 RsrLab,Associatesof CapeCod, Inc,Falmouth,MA,USA 411 Use of Mass Cytometry to Study Cellular Subsets in CSF and Blood in ART-Treated HIV Shang-Lin Chung 1 ; DianeTrotta 1 ; Leah Le 1 ; Laurie Andrews 2 ; Jennifer Chiarella 1 ; Khadir Raddassi 1 ; Serena S. Spudich 1 ; Brinda Emu 1 1 YaleUnivSchofMed,NewHaven,CT,USA; 2 YaleUnivSchofMed,New Haven,CT,USA 412 CNS Drug Distribution and CSF Inflammation During Suppressive Antiretroviral Therapy Albert Anderson 1 ; Jennifer Iudicello 2 ; Asha R. Kallianpur 3 ; Karen Tolentino 2 ; Ron Ellis 2 ; Igor Grant 4 ;Todd Hulgan 5 ; Scott R. Letendre 2 ; for the CHARTER Group 1 EmoryUniv,Atlanta,GA,USA; 2 UnivofCaliforniaSanDiego,SanDiego, CA,USA; 3 ClevelandClinic/LernerRsr Inst,Cleveland,OH,USA; 4 Univ ofCaliforniaSanDiego,La Jolla,CA,USA; 5 VanderbiltUniv,Nashville, TN,USA 410 (1 3)-ß-D-Glucan Levels CorrelateWith Neurocognitive Functioning in HIV Infection

Poster Listings

CROI 2016 109